The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-(7-(2-(2-(2-(3-tert-butylureido)ethoxy)ethoxy)phenyl)thieno[2,3-d]pyridazin-4-ylamino)-3-fluorophenyl)acetamide ID: ALA4539293
PubChem CID: 155549911
Max Phase: Preclinical
Molecular Formula: C29H33FN6O4S
Molecular Weight: 580.69
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)NC(=O)NCCOCCOc1ccccc1-c1nnc(Nc2ccc(CC(N)=O)cc2F)c2ccsc12
Standard InChI: InChI=1S/C29H33FN6O4S/c1-29(2,3)34-28(38)32-11-12-39-13-14-40-23-7-5-4-6-19(23)25-26-20(10-15-41-26)27(36-35-25)33-22-9-8-18(16-21(22)30)17-24(31)37/h4-10,15-16H,11-14,17H2,1-3H3,(H2,31,37)(H,33,36)(H2,32,34,38)
Standard InChI Key: BLVLCHZGMIMJLQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
41 44 0 0 0 0 0 0 0 0999 V2000
19.7240 -28.7420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9007 -26.2931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6104 -25.8837 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6076 -25.0610 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8989 -24.6558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1927 -25.8842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1939 -25.0676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4177 -24.8141 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.9367 -25.4740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4157 -26.1352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8938 -23.8438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6012 -23.4326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5978 -22.6162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8877 -22.2100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1795 -22.6263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1864 -23.4413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9005 -27.1103 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6081 -27.5191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6038 -28.3345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3106 -28.7432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0194 -28.3347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0169 -27.5133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3096 -27.1083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4348 -28.3332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1429 -28.7410 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.4339 -27.5160 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.8949 -28.7410 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.3104 -23.8387 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0166 -23.4275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7258 -23.8336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4320 -23.4225 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1412 -23.8285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8474 -23.4174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5566 -23.8235 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2629 -23.4123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.9720 -23.8184 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.2599 -22.5952 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.6783 -23.4073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3874 -23.8133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6753 -22.5901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3825 -22.9928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 7 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 11 1 0
2 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 1 1 0
1 24 1 0
24 25 1 0
24 26 2 0
19 27 1 0
12 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
35 37 2 0
36 38 1 0
38 39 1 0
38 40 1 0
38 41 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 580.69Molecular Weight (Monoisotopic): 580.2268AlogP: 4.76#Rotatable Bonds: 12Polar Surface Area: 140.49Molecular Species: NEUTRALHBA: 8HBD: 4#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 1CX Acidic pKa: 12.93CX Basic pKa: 1.81CX LogP: 3.45CX LogD: 3.45Aromatic Rings: 4Heavy Atoms: 41QED Weighted: 0.18Np Likeness Score: -1.78
References 1. Tsuji T, Yamaguchi M, Kuroyanagi J, Furuzono S, Konishi M, Terayama K, Tanaka J, Saito M, Kobayashi Y.. (2019) Discovery of novel pyridazine derivatives as glucose transporter type 4 (GLUT4) translocation activators., 29 (14): [PMID:31101471 ] [10.1016/j.bmcl.2019.05.013 ]